<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7287466\results\search\disease\results.xml">
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="myalgia and central nervous pathologies warrants future exploration. Abstract Emerging" exact="Viral" post="diseases are incredibly infectious and proficient in inducing pandemics."/>
  <result pre="pathologies warrants future exploration. Abstract Emerging Viral diseases are incredibly" exact="infectious" post="and proficient in inducing pandemics. Unlike the previous emerging"/>
  <result pre="presenting with CNS involvement in up to 25%, musculoskeletal and" exact="peripheral" post="manifestation (PNM). Through preceding ECoVs case reports, the PNM"/>
  <result pre="Ageusia Myalgia Anticoagulants Methylprednisolone 1 Introduction The emergence of an" exact="infectious" post="disorder usually involves multiple factors, for instance, vectors' ecological"/>
  <result pre="be typically benign. Further, the mammalian host often is an" exact="intermediate" post="transmission agent [2]. Additionally, EV diseases are extraordinarily infectious"/>
  <result pre="an intermediate transmission agent [2]. Additionally, EV diseases are extraordinarily" exact="infectious" post="and proficient of inducing epidemics as evidenced by outbreaks"/>
  <result pre="virus 1994 and 1998 sequentially, and CoV: coronaviruses (SARS-CoV: severe" exact="acute" post="respiratory syndrome, MERS-CoV: Middle East Respiratory Syndrome, and SARS-CoV-2)"/>
  <result pre="1994 and 1998 sequentially, and CoV: coronaviruses (SARS-CoV: severe acute" exact="respiratory" post="syndrome, MERS-CoV: Middle East Respiratory Syndrome, and SARS-CoV-2) in"/>
  <result pre="CoV: coronaviruses (SARS-CoV: severe acute respiratory syndrome, MERS-CoV: Middle East" exact="Respiratory" post="Syndrome, and SARS-CoV-2) in 2003, 2012 and 2019 successively"/>
  <result pre="and are associated with human and diverse animal infections. They" exact="acquired" post="the name due to unique presentation of virions under"/>
  <result pre="novel viruses [12]. Even though CoVs commonly recognized for inducing" exact="respiratory" post="ailments, both clinical and experimental research types have illustrated"/>
  <result pre="fully [8], [13]. However, there is actual proof that human" exact="respiratory" post="CoVs can manifest with extra respiratory manifestations, including neuroinvasive"/>
  <result pre="actual proof that human respiratory CoVs can manifest with extra" exact="respiratory" post="manifestations, including neuroinvasive features; indeed, SARS-CoV, the OC43 CoV,"/>
  <result pre="SARS-CoV, the OC43 CoV, and 229E CoV detected in the" exact="brain" post="tissues of autopsied SARS cases and multiple sclerosis cases"/>
  <result pre="detected in the brain tissues of autopsied SARS cases and" exact="multiple sclerosis" post="cases [12], [14]. Similarly, reported a new neurological manifestation"/>
  <result pre="new neurological manifestation among the COVID-19 confirmed cases [15]. Unlike" exact="respiratory" post="presentations of ECoVs, which are well investigated, there is"/>
  <result pre="case reporting need be advanced, aiming at creation of the" exact="infection" post="control models and venture clinical trials for therapies advancements"/>
  <result pre="pharmacological options. 2 Epidemiology Numerous viruses can contaminate the mammalian" exact="central nervous system" post="(CNS), some with overwhelming outcomes, others ending with chronic"/>
  <result pre="nervous system (CNS), some with overwhelming outcomes, others ending with" exact="chronic" post="infections [18]. The mortality of encephalitis secondary to viral"/>
  <result pre="system (CNS), some with overwhelming outcomes, others ending with chronic" exact="infections" post="[18]. The mortality of encephalitis secondary to viral infections"/>
  <result pre="outcomes, others ending with chronic infections [18]. The mortality of" exact="encephalitis" post="secondary to viral infections extends from 4 to 29%,"/>
  <result pre="others ending with chronic infections [18]. The mortality of encephalitis" exact="secondary" post="to viral infections extends from 4 to 29%, and"/>
  <result pre="with chronic infections [18]. The mortality of encephalitis secondary to" exact="viral" post="infections extends from 4 to 29%, and approximately 50%"/>
  <result pre="chronic infections [18]. The mortality of encephalitis secondary to viral" exact="infections" post="extends from 4 to 29%, and approximately 50% of"/>
  <result pre="study involving 183 hospitalized pediatrics cases presenting with CNS and" exact="acute" post="respiratory tract infection (ARI), CoV infection observed in 12.02%"/>
  <result pre="involving 183 hospitalized pediatrics cases presenting with CNS and acute" exact="respiratory" post="tract infection (ARI), CoV infection observed in 12.02% of"/>
  <result pre="hospitalized pediatrics cases presenting with CNS and acute respiratory tract" exact="infection" post="(ARI), CoV infection observed in 12.02% of the cases"/>
  <result pre="presenting with CNS and acute respiratory tract infection (ARI), CoV" exact="infection" post="observed in 12.02% of the cases presenting with CNS"/>
  <result pre="followed by headache and vomiting [19]. It is apparent that" exact="infection" post="by the SARS virus not restricted to the lungs,"/>
  <result pre="SARS virus not restricted to the lungs, but also exhibits" exact="systemic" post="complications, as evidenced by 65 cases with hallmark of"/>
  <result pre="lymphocyte destruction; further, extensive propagation of the SARS virus into" exact="cerebral" post="neurons demonstrated from the 8 SARS confirmed cases based"/>
  <result pre="out of every 5 MERS-CoV cases before or after the" exact="viral" post="confirmation [21]. In one of the first retrospective studies"/>
  <result pre="assessing the intensive care unit (ICU) MERS-CoV cases, severe neurological" exact="syndrome" post="with fluctuating rates of altered consciousness, ataxia, localized motor"/>
  <result pre="severe neurological syndrome with fluctuating rates of altered consciousness, ataxia," exact="localized" post="motor disturbances, and hyperintense lesions bilaterally was observed among"/>
  <result pre="cases to present with confusion and more than 8% with" exact="seizure" post="presentation [23]. Neurological pathologies secondary to MERS treatment abundantly"/>
  <result pre="and more than 8% with seizure presentation [23]. Neurological pathologies" exact="secondary" post="to MERS treatment abundantly observed [24]. Similar to SARS-CoV,"/>
  <result pre="MERS treatment abundantly observed [24]. Similar to SARS-CoV, the MERS-CoV" exact="infection" post="exhibits systemic complications, and CNS involvement appears to be"/>
  <result pre="abundantly observed [24]. Similar to SARS-CoV, the MERS-CoV infection exhibits" exact="systemic" post="complications, and CNS involvement appears to be another target"/>
  <result pre="In contrast, neuropathic pain, gustatory/olfaction dysfunctions, and ophthalmic pathologies affect" exact="peripheral" post="and musculoskeletal systems [15], [25]. Populationally (Table1 ), during"/>
  <result pre="the majority of the death due to comorbidities such as" exact="diabetes" post="(DM), cardiac pathologies (CAP), or a weak body immunity"/>
  <result pre="in those with the underlying medical conditions like DM, CAP," exact="hypertension" post="(HTN) or chronic renal failure (CRF), meanwhile, the case"/>
  <result pre="with the underlying medical conditions like DM, CAP, hypertension (HTN)" exact="or chronic" post="renal failure (CRF), meanwhile, the case fatality rate was"/>
  <result pre="the underlying medical conditions like DM, CAP, hypertension (HTN) or" exact="chronic" post="renal failure (CRF), meanwhile, the case fatality rate was"/>
  <result pre="underlying medical conditions like DM, CAP, hypertension (HTN) or chronic" exact="renal failure" post="(CRF), meanwhile, the case fatality rate was approximately 35%"/>
  <result pre="years, concurrently, nearly 17% of the HCW reported with SARS-CoV" exact="infection" post="[31], [32]. In the most contemporary ECoV pandemic, the"/>
  <result pre="with pyrexia, other symptoms incorporated cough, myalgia, headache, hemoptysis, and" exact="diarrhea" post="[34], [35]. Aetiologically, SARS-CoV, in which the epicenter was"/>
  <result pre="SARS coronavirus arose from bats from which it infected diverse" exact="intermediate" post="mammalians. Furthermore, this transformation to dissimilar hosts needed the"/>
  <result pre="hosts needed the CoV to bear mutation for humans then" exact="acquired" post="the virus; nonetheless, the virus looks to have needed"/>
  <result pre="as the reservoir and the principal source of human MERS-CoV" exact="infections" post="[9], [36]. Additionally, up-to-date findings have confirmed bats to"/>
  <result pre="human transmission published [34], [38], [39]. 3 Clinical presentation 3.1" exact="General" post="clinical presentation While earlier ECoVs neurological complexities did not"/>
  <result pre="ECoVs neurological complexities did not appear to arise simultaneously with" exact="respiratory" post="manifestations, instead exhibited delay by 14â€&quot;21Â days, in the"/>
  <result pre="and the presence of 1 or more other symptoms of" exact="lower" post="lungs (cough, troubled breathing, shortness of breathing) and radiographic"/>
  <result pre="of breathing) and radiographic proof of lung infiltrates compatible with" exact="pneumonia" post="and non-existence of alternative diagnosis that can thoroughly describe"/>
  <result pre="and non-existence of alternative diagnosis that can thoroughly describe the" exact="disease" post="[40]. The initial chest CT usually displays patchy consolidation"/>
  <result pre="diagnosis that can thoroughly describe the disease [40]. The initial" exact="chest" post="CT usually displays patchy consolidation originating with a single"/>
  <result pre="chest CT usually displays patchy consolidation originating with a single" exact="peripheral" post="lesion that advances to multiplied lesions or ground glass"/>
  <result pre="or ground glass presentation. Meanwhile, on full blood picture (FBP)," exact="lymphopenia" post="often remarked and advances during the illness; seldom, thrombocytopenia"/>
  <result pre="(FBP), lymphopenia often remarked and advances during the illness; seldom," exact="thrombocytopenia" post="and prolonged APTT identified, nonetheless, raised LDH levels is"/>
  <result pre="prediction [41]. By contrast, MERS begins with pyrexia, cough, pharyngitis," exact="muscle" post="aches, and joints pain, succeeded by dyspnoea, and fast"/>
  <result pre="and joints pain, succeeded by dyspnoea, and fast progress to" exact="pneumonia" post="in 7Â days, frequently warrants ventilatory assistance [42]. Abnormal"/>
  <result pre="pneumonia in 7Â days, frequently warrants ventilatory assistance [42]. Abnormal" exact="chest" post="X-rays are more prevalent than in SARS cases, with"/>
  <result pre="(pyrexia, cough dry in nature, dyspnoea, and ground-glass opacities on" exact="chest" post="CT scans in up to 98% two-sided entanglement) between"/>
  <result pre="up to 98% two-sided entanglement) between SARS-CoV-2 and preceding ECoV" exact="infections" post="noted. However, few cases with SARS-CoV-2 an infection had"/>
  <result pre="preceding ECoV infections noted. However, few cases with SARS-CoV-2 an" exact="infection" post="had striking upper respiratory tract signs and symptoms and"/>
  <result pre="noted. However, few cases with SARS-CoV-2 an infection had striking" exact="upper" post="respiratory tract signs and symptoms and infrequently exhibited GIT"/>
  <result pre="However, few cases with SARS-CoV-2 an infection had striking upper" exact="respiratory" post="tract signs and symptoms and infrequently exhibited GIT manifestations"/>
  <result pre="compared to the previous ECoV cases. Moreover, IFN-Î³-inducible protein 10," exact="Monocyte" post="chemoattractant protein 1, MIP1A, and TNFÎ± presence rises as"/>
  <result pre="SARS-CoV-2 with RT-PCR [48], [49]. 3.2 Neurological presentation 3.2.1 The" exact="central nervous system" post="manifestation Critical acute neurologic pathologies infrequently characterize ECoV; in"/>
  <result pre="3.2 Neurological presentation 3.2.1 The central nervous system manifestation Critical" exact="acute" post="neurologic pathologies infrequently characterize ECoV; in one study, status"/>
  <result pre="Critical acute neurologic pathologies infrequently characterize ECoV; in one study," exact="status epilepticus" post="(SE) has shown to be the manifesto of the"/>
  <result pre="Cerebrospinal fluid (CSF). Further, SE is recognized to be a" exact="seizure" post="lasting for 5â€&quot;30Â min or longer without annulling automatically,"/>
  <result pre="5â€&quot;30Â min or longer without annulling automatically, or either as" exact="seizures" post="repeatedly reappearing with no full consciousness restoration amid succeeding"/>
  <result pre="days post-admission in 59Â years lady, SE presented with reappearing" exact="seizures" post="not responding to phenytoin treatment and extended episodes up"/>
  <result pre="positive for both CSF and serum specimen, while the CSF" exact="viral" post="load was 6884 copies/mL and serum viral load was"/>
  <result pre="while the CSF viral load was 6884 copies/mL and serum" exact="viral" post="load was 6750 copies/mL. Besides, chances of metabolic disarrangements,"/>
  <result pre="viral load was 6750 copies/mL. Besides, chances of metabolic disarrangements," exact="renal failure," post="stroke, cranial trauma, and hypoxia excluded [16], [50]. Similarly,"/>
  <result pre="chances of metabolic disarrangements, renal failure, stroke, cranial trauma, and" exact="hypoxia" post="excluded [16], [50]. Similarly, SARS CoV entry into the"/>
  <result pre="pregnancy might present with generalized seizure, as a rule, excluding" exact="eclampsia" post="by noting blood pressure and proteinuria is mandatory. Moreover,"/>
  <result pre="seizure, as a rule, excluding eclampsia by noting blood pressure" exact="and proteinuria" post="is mandatory. Moreover, ruling out the likelihood of drug"/>
  <result pre="mandatory. Moreover, ruling out the likelihood of drug toxicity (Ribavirin)," exact="acute" post="renal failure (ARF), Acid-base changes, and CNS infection obliged."/>
  <result pre="Moreover, ruling out the likelihood of drug toxicity (Ribavirin), acute" exact="renal failure" post="(ARF), Acid-base changes, and CNS infection obliged. In the"/>
  <result pre="toxicity (Ribavirin), acute renal failure (ARF), Acid-base changes, and CNS" exact="infection" post="obliged. In the inadequacy of contraindications, a lumbar puncture"/>
  <result pre="approximately 25% of the cases. Further, the recent onset of" exact="seizures" post="reported as a manifestation of SARS-CoV-2 encephalitis and meningitis."/>
  <result pre="recent onset of seizures reported as a manifestation of SARS-CoV-2" exact="encephalitis" post="and meningitis. They are associated with confusion and loss"/>
  <result pre="RT-PCR rather than a nasopharyngeal swab [52], [53], [54], [55]." exact="Acute" post="cerebrovascular accident (CVA) is not unusual in critically ill"/>
  <result pre="rather than a nasopharyngeal swab [52], [53], [54], [55]. Acute" exact="cerebrovascular accident" post="(CVA) is not unusual in critically ill cases with"/>
  <result pre="ill cases with multiple co-morbidity. On the contrary, large vessel" exact="cerebral" post="infarctions (LVCI) are rare among SARS cases, but when"/>
  <result pre="In one prospective study involving 5 cases, LVCI showed high" exact="susceptibility to" post="thromboembolic episodes, with up to 1/3 of the critically"/>
  <result pre="to 1/3 of the critically ill cases ended up with" exact="deep vein thrombosis" post="and hypercoagulable state [56], [57]. Table 2 The central"/>
  <result pre="of the critically ill cases ended up with deep vein" exact="thrombosis" post="and hypercoagulable state [56], [57]. Table 2 The central"/>
  <result pre="vein thrombosis and hypercoagulable state [56], [57]. Table 2 The" exact="central nervous system" post="manifestation of the emerging corona viruses (SARS/MERS). Case Author/Year"/>
  <result pre="Status 1. Hung, 2003 45/F Status epilepticus Serum+VE/CSF +VESARS-CoV CT:" exact="Normal" post="RND, fungal peritonitis A 2. Lau, 2004 32/F Generalized"/>
  <result pre="2003 45/F Status epilepticus Serum+VE/CSF +VESARS-CoV CT: Normal RND, fungal" exact="peritonitis" post="A 2. Lau, 2004 32/F Generalized seizure Serum+VE/CSF +VESARS-CoV"/>
  <result pre="CT: Normal RND, fungal peritonitis A 2. Lau, 2004 32/F" exact="Generalized" post="seizure Serum+VE/CSF +VESARS-CoV Normal MRI, EEG Pregnancy A 3."/>
  <result pre="Normal RND, fungal peritonitis A 2. Lau, 2004 32/F Generalized" exact="seizure" post="Serum+VE/CSF +VESARS-CoV Normal MRI, EEG Pregnancy A 3. Umapathi,"/>
  <result pre="peritonitis A 2. Lau, 2004 32/F Generalized seizure Serum+VE/CSF +VESARS-CoV" exact="Normal" post="MRI, EEG Pregnancy A 3. Umapathi, 2004 68/F LVCI"/>
  <result pre="Lau, 2004 32/F Generalized seizure Serum+VE/CSF +VESARS-CoV Normal MRI, EEG" exact="Pregnancy" post="A 3. Umapathi, 2004 68/F LVCI Serum+VESARS-CoV Brain CT:"/>
  <result pre="MRI, EEG Pregnancy A 3. Umapathi, 2004 68/F LVCI Serum+VESARS-CoV" exact="Brain" post="CT: Infarction no vascular risk factors A 4 64/F"/>
  <result pre="Pregnancy A 3. Umapathi, 2004 68/F LVCI Serum+VESARS-CoV Brain CT:" exact="Infarction" post="no vascular risk factors A 4 64/F LVCI Serum+VESARS-CoV"/>
  <result pre="3. Umapathi, 2004 68/F LVCI Serum+VESARS-CoV Brain CT: Infarction no" exact="vascular" post="risk factors A 4 64/F LVCI Serum+VESARS-CoV Brain CT:"/>
  <result pre="Infarction no vascular risk factors A 4 64/F LVCI Serum+VESARS-CoV" exact="Brain" post="CT: MCA infarction no stroke risk factors D 5"/>
  <result pre="A 4 64/F LVCI Serum+VESARS-CoV Brain CT: MCA infarction no" exact="stroke" post="risk factors D 5 54/F LVCI Serum+VE/SARS-CoV Brain CT"/>
  <result pre="infarction no stroke risk factors D 5 54/F LVCI Serum+VE/SARS-CoV" exact="Brain" post="CT PCA and MCA Dyslipidaemia and hyperthyroidism D 6"/>
  <result pre="54/F LVCI Serum+VE/SARS-CoV Brain CT PCA and MCA Dyslipidaemia and" exact="hyperthyroidism" post="D 6 63/M LVCI Serum+VE/CSF âˆ’VESARS-CoV Brain CT: infarction"/>
  <result pre="MCA Dyslipidaemia and hyperthyroidism D 6 63/M LVCI Serum+VE/CSF âˆ’VESARS-CoV" exact="Brain" post="CT: infarction DM, HTN, IHD A 7 39/M Right"/>
  <result pre="7 39/M Right occipital lobeInfartion (Autopsy) Serum+VE/CSF âˆ’VESARS-CoV â€&quot; no" exact="stroke" post="risk factors D 8 Arabi, 2015 74/M Acute disseminated"/>
  <result pre="â€&quot; no stroke risk factors D 8 Arabi, 2015 74/M" exact="Acute" post="disseminated encephalomyelitis Serum+VE/CSF âˆ’VE MERS-CoVâ†‘protein MRI T2/FLAIR: hyperdense lesions"/>
  <result pre="stroke risk factors D 8 Arabi, 2015 74/M Acute disseminated" exact="encephalomyelitis" post="Serum+VE/CSF âˆ’VE MERS-CoVâ†‘protein MRI T2/FLAIR: hyperdense lesions DM, HTN"/>
  <result pre="Serum+VE/CSF âˆ’VE MERS-CoVâ†‘protein MRI T2/FLAIR: hyperdense lesions DM, HTN and" exact="dyslipidemia" post="D 9 57/M Vasculopathy Serum+VE MERS-CoVCSF -No CT: patchy"/>
  <result pre="-No CT: patchy hypodense lesions DM, HTN D 10 45/M" exact="Encephalitis" post="Serum+VE/CSF âˆ’VE MERS-CoVâ†‘protein MRI T2/FLAIR: hyperdense lesions DM, HTN,"/>
  <result pre="hyperdense lesions DM, HTN, PAD A 11 Al-Hameed, 2017 42/F" exact="Spontaneous" post="ICH Serum+VEMERS-CoV CT: SAH RND, DM D ABBREVIATION: LVC"/>
  <result pre="CT: SAH RND, DM D ABBREVIATION: LVC â€&quot; large vessel" exact="cerebral" post="infarctions, ICH Intracranial Hemorrhage, +VE â€&quot; Positive, -VE â€&quot;"/>
  <result pre="Positive, -VE â€&quot; Negative, CSF â€&quot; Cerebrospinal fluid, RND â€&quot;" exact="Renal" post="Disease, DM â€&quot; Diabetes mellitus, HTN â€&quot; Hypertension, PAD"/>
  <result pre="CSF â€&quot; Cerebrospinal fluid, RND â€&quot; Renal Disease, DM â€&quot;" exact="Diabetes mellitus," post="HTN â€&quot; Hypertension, PAD â€&quot; peripheral artery disease, Hypertension,"/>
  <result pre="Disease, DM â€&quot; Diabetes mellitus, HTN â€&quot; Hypertension, PAD â€&quot;" exact="peripheral artery disease," post="Hypertension, IHD â€&quot; Ischemic hart disease, A â€&quot; Alive,"/>
  <result pre="DM â€&quot; Diabetes mellitus, HTN â€&quot; Hypertension, PAD â€&quot; peripheral" exact="artery disease," post="Hypertension, IHD â€&quot; Ischemic hart disease, A â€&quot; Alive,"/>
  <result pre="years man with comorbidities (DM, HTN, and dyslipidemia) revealed no" exact="acute" post="changes rather than multiple chronic small vessels (lacunar) strokes."/>
  <result pre="HTN, and dyslipidemia) revealed no acute changes rather than multiple" exact="chronic" post="small vessels (lacunar) strokes. Surprisingly the MRI repeated three"/>
  <result pre="MRI repeated three weeks later had remarkable findings of various" exact="bilateral" post="patchy regions of signal anomaly that appeared high on"/>
  <result pre="peri-ventricular, deep white matter, subcortical region. The observation implied an" exact="acute" post="disseminated encephalomyelitis (ADEM). Of note, this case presented with"/>
  <result pre="white matter, subcortical region. The observation implied an acute disseminated" exact="encephalomyelitis" post="(ADEM). Of note, this case presented with high-grade fever,"/>
  <result pre="this case presented with high-grade fever, altered mental level, with" exact="ataxia" post="and focal motor deficits. Ended up into coma and"/>
  <result pre="presented with high-grade fever, altered mental level, with ataxia and" exact="focal motor" post="deficits. Ended up into coma and died 30Â days"/>
  <result pre="multiple comorbidities, ended with spontaneous intraventricular hemorrhage [60]. 3.2.2 The" exact="peripheral" post="nervous system manifestation Peripheral nerve dysfunctions regularly induced by"/>
  <result pre="intraventricular hemorrhage [60]. 3.2.2 The peripheral nervous system manifestation Peripheral" exact="nerve" post="dysfunctions regularly induced by dysfunction of the peripheral motor,"/>
  <result pre="manifestation Peripheral nerve dysfunctions regularly induced by dysfunction of the" exact="peripheral" post="motor, sensory, or autonomic nerves. Similar to CNS ECoV"/>
  <result pre="sensory, or autonomic nerves. Similar to CNS ECoV related disorders," exact="peripheral" post="nervous system (PNS) disorders does not coincide with the"/>
  <result pre="disorders (NMD) in these cases observed to fall under critical-illness" exact="polyneuropathy" post="(CIP), myopathy (CIM), or both. Amongst the cases exhibited"/>
  <result pre="in these cases observed to fall under critical-illness polyneuropathy (CIP)," exact="myopathy" post="(CIM), or both. Amongst the cases exhibited polyneuropathy, the"/>
  <result pre="NCSs revealed decreased CMAP amplitudes. Never the less, diminishing of" exact="nerve" post="conduction velocity, temporal dispersion or conduction block, does not"/>
  <result pre="peculiarity of SARS-NMD. On the other side, the EMG explicated" exact="acute" post="denervation. Of note, large doses of intravenous corticosteroid treatment"/>
  <result pre="Of note, large doses of intravenous corticosteroid treatment may generate" exact="acute" post="steroid myopathy [57], [61]. Further, regarding myopathy and rhabdomyolysis,"/>
  <result pre="note, large doses of intravenous corticosteroid treatment may generate acute" exact="steroid myopathy" post="[57], [61]. Further, regarding myopathy and rhabdomyolysis, a pair"/>
  <result pre="large doses of intravenous corticosteroid treatment may generate acute steroid" exact="myopathy" post="[57], [61]. Further, regarding myopathy and rhabdomyolysis, a pair"/>
  <result pre="treatment may generate acute steroid myopathy [57], [61]. Further, regarding" exact="myopathy" post="and rhabdomyolysis, a pair of commonly suggested mechanisms are"/>
  <result pre="and rhabdomyolysis, a pair of commonly suggested mechanisms are direct" exact="muscle" post="invasion by ECoV particles and immune-mediated muscle injury, satisfactory"/>
  <result pre="mechanisms are direct muscle invasion by ECoV particles and immune-mediated" exact="muscle" post="injury, satisfactory proof of the direct invasion of SARS"/>
  <result pre="proof of the direct invasion of SARS CoV into the" exact="muscle" post="cells is still lacking [57], [62]. In one postmortem"/>
  <result pre="cells is still lacking [57], [62]. In one postmortem skeletal" exact="muscle" post="research based on 8 SARS cases, the diagnosis of"/>
  <result pre="based on 8 SARS cases, the diagnosis of critical illness" exact="myopathy" post="(CIM) was verified based on clinical features; namely, generalized"/>
  <result pre="creatine kinase, and histological features. Besides, the nonexistence of myofiber" exact="atrophy" post="in subjects with no steroid treatment proposes the contribution"/>
  <result pre="essential agent in the CIM mechanism [63], [64]. The viral-induced" exact="myositis" post="proposed owing to the abundance cases manifesting with myalgia"/>
  <result pre="of the SARS cases had raised serum CK levels with" exact="myopathy" post="exhibiting with significant myofiber atrophy particularly for cases in"/>
  <result pre="raised serum CK levels with myopathy exhibiting with significant myofiber" exact="atrophy" post="particularly for cases in whom hydrocortisone administered. Never the"/>
  <result pre="studies expected to explore whether this is a feature of" exact="viral" post="effected myositis like previous ECoV [34], [63], [64]. Despite"/>
  <result pre="to explore whether this is a feature of viral effected" exact="myositis" post="like previous ECoV [34], [63], [64]. Despite of neuromusculoskeletal"/>
  <result pre="[34], [63], [64]. Despite of neuromusculoskeletal sequelae, SARS victims endured" exact="periodic" post="relief of pain and weakness recovery following conservative management"/>
  <result pre="recovery following conservative management and resumed daily activities [65]. CIM" exact="and neuropathy" post="are underdiagnosed pathologies in the ICU contexts and propose"/>
  <result pre="following conservative management and resumed daily activities [65]. CIM and" exact="neuropathy" post="are underdiagnosed pathologies in the ICU contexts and propose"/>
  <result pre="with limb weakness or ventilator dependence with no cardiac or" exact="pulmonary" post="pathologies. In a case series report involving 4 confirmed"/>
  <result pre="comorbidities, ended up with ICU care, neurological testing revealed symmetrical" exact="lower" post="limb weakness, with intact sensations, mildly decreased deep tendon"/>
  <result pre="Guillain Barre syndrome, botulinum toxin susceptibility, continuing neuromuscular blockade, and" exact="Lambert-Eaton myasthenic syndrome" post="[21], [66]. Furthermore, olfactory neuropathy has reported as a"/>
  <result pre="syndrome, botulinum toxin susceptibility, continuing neuromuscular blockade, and Lambert-Eaton myasthenic" exact="syndrome" post="[21], [66]. Furthermore, olfactory neuropathy has reported as a"/>
  <result pre="neuromuscular blockade, and Lambert-Eaton myasthenic syndrome [21], [66]. Furthermore, olfactory" exact="neuropathy" post="has reported as a rare form of typical peripheral"/>
  <result pre="olfactory neuropathy has reported as a rare form of typical" exact="peripheral neuropathy" post="induced by SARS-CoV. When dealing with cases of ECoV"/>
  <result pre="neuropathy has reported as a rare form of typical peripheral" exact="neuropathy" post="induced by SARS-CoV. When dealing with cases of ECoV"/>
  <result pre="lobe meningioma, a lesion in the sub frontal region, nasal" exact="cavities" post="and paranasal sinuses by MRI. Moreover, neurodegenerative disorders, and"/>
  <result pre="the only neurological sign in mild cases [69]. Guillain BarrÃ©" exact="syndrome" post="(GBS) accompanied by COVID-19 may cause PNS quandary, even"/>
  <result pre="(GBS) accompanied by COVID-19 may cause PNS quandary, even ere" exact="respiratory" post="manifestations resolve, principally displaying fast-evolving quadriplegia, raised protein level,"/>
  <result pre="yet negative CSF RT-PCR stated [70], [71]. The COVID 19" exact="Miller Fisher syndrome" post="(MFS) symptoms preceded by infection and presented with ageusia,"/>
  <result pre="negative CSF RT-PCR stated [70], [71]. The COVID 19 Miller" exact="Fisher syndrome" post="(MFS) symptoms preceded by infection and presented with ageusia,"/>
  <result pre="CSF RT-PCR stated [70], [71]. The COVID 19 Miller Fisher" exact="syndrome" post="(MFS) symptoms preceded by infection and presented with ageusia,"/>
  <result pre="The COVID 19 Miller Fisher syndrome (MFS) symptoms preceded by" exact="infection" post="and presented with ageusia, bilateral abducent nerve palsy, areflexia,"/>
  <result pre="syndrome (MFS) symptoms preceded by infection and presented with ageusia," exact="bilateral" post="abducent nerve palsy, areflexia, and albuminocytologic dissociation, Moreover the"/>
  <result pre="symptoms preceded by infection and presented with ageusia, bilateral abducent" exact="nerve" post="palsy, areflexia, and albuminocytologic dissociation, Moreover the interface between"/>
  <result pre="reported proposing a para/postviral consequences [72]. 3.2.3 The central and" exact="peripheral" post="nervous system co-existence manifestation There is evidence that ECoV"/>
  <result pre="evidence that ECoV neurological symptoms may overlap as in Bickerstaffâ€™s" exact="encephalitis" post="(BBE) overlapping with GBS in MERS cases, it is"/>
  <result pre="[73]. Mimics require exclusion with the aid of clinical history," exact="cerebral" post="MRI, and CSF conclusions whereby CSF albuminocytologic dissociation and"/>
  <result pre="[76]. The ongoing multicenter, randomized controlled trial, the MIRACLE (MERS-CoV" exact="Infection" post="treated with A Combination of LPV/r and intErferon-Î²1b) trial"/>
  <result pre="antiviral therapy [75]. Neurologically, SARS-CoV, and COVID-19 cases presented with" exact="seizures" post="managed by propofol, phenytoin, and Levetiracetam. Valproate and midazolam"/>
  <result pre="spray steroids and oral cobalamin prescribed in the management of" exact="acute" post="CN I inflammation, yet anosmia endured during follow-up to"/>
  <result pre="critical case management, aiming to reduce the inflammation and influence" exact="pulmonary" post="damage. Still, contemporary data in SARS and MERS cases"/>
  <result pre="implies no benefit of corticosteroid on mortality rather than prolonged" exact="viral" post="clearing [16]. Intravenous methylprednisolone has been used supportively in"/>
  <result pre="54.5% with accompanied comorbidities in (8/11) 72%, while those with" exact="peripheral" post="manifestation were not likely to present with fatal outcomes."/>
  <result pre="peripherally manifest as CIP, CIM, BBE overlapping with GBS, ICU" exact="acquired" post="GBS and CN I neuropathy, and obesity is a"/>
  <result pre="overlapping with GBS, ICU acquired GBS and CN I neuropathy," exact="and obesity" post="is a significant risk factor. Furthermore, it is mandatory"/>
  <result pre="with GBS, ICU acquired GBS and CN I neuropathy, and" exact="obesity" post="is a significant risk factor. Furthermore, it is mandatory"/>
  <result pre="interest regarding the publication of this research. References References 1BaleJ.F.Emerging" exact="viral" post="infectionsSeminars Pediatric Neurol1932012152157 2DimmockN.J.EastonA.J.LeppardK.N.Introduction to modern virologySeventh edition2016University of"/>
  <result pre="the publication of this research. References References 1BaleJ.F.Emerging viral infectionsSeminars" exact="Pediatric" post="Neurol1932012152157 2DimmockN.J.EastonA.J.LeppardK.N.Introduction to modern virologySeventh edition2016University of WarwickCoventry 3ZhuN.ZhangD.WangW.A"/>
  <result pre="virologySeventh edition2016University of WarwickCoventry 3ZhuN.ZhangD.WangW.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med2020NEJMoa2001017 4KumarB.ManujaA.GulatiB.VirmaniN.TripathiB.N.Zoonotic viral diseases"/>
  <result pre="patients with pneumonia in China, 2019N Engl J Med2020NEJMoa2001017 4KumarB.ManujaA.GulatiB.VirmaniN.TripathiB.N.Zoonotic" exact="viral" post="diseases of equines and their impact on human and"/>
  <result pre="their impact on human and animal healthTOVJ1212018809830288197 5European Centre for" exact="Disease" post="Prevention and Control. Rapid Risk Assessment: Outbreak of acute"/>
  <result pre="for Disease Prevention and Control. Rapid Risk Assessment: Outbreak of" exact="acute" post="respiratory syndrome associated with a novel coronavirus, Wuhan, China;"/>
  <result pre="Disease Prevention and Control. Rapid Risk Assessment: Outbreak of acute" exact="respiratory" post="syndrome associated with a novel coronavirus, Wuhan, China; first"/>
  <result pre="Prevention and Control. Rapid Risk Assessment: Outbreak of acute respiratory" exact="syndrome" post="associated with a novel coronavirus, Wuhan, China; first update"/>
  <result pre="CA: Academic Press, 2017. Print. 10WHO Statement Regarding Cluster of" exact="Pneumonia" post="Cases in Wuhan, China Geneva2020 [updated 9 January 202014"/>
  <result pre="2020]. Available from: https://www.who.int/china/news/detail/09-01-2020-whostatement-regarding-cluster-of-pneumonia-cases-in-wuhan-china.(accessed Jan 25, 2020). 11European Centre for" exact="Disease" post="Prevention and Control. Cluster of pneumonia cases caused by"/>
  <result pre="2020). 11European Centre for Disease Prevention and Control. Cluster of" exact="pneumonia" post="cases caused by a novel coronavirus, Wuhan, China; â€&quot;"/>
  <result pre="ECDC: Stockholm; 2020 (accessed Jan 25, 2020). 12PrincipiN.BosisS.EspositoS.Effects of coronavirus" exact="infections" post="in childrenEmerg Infect Dis162201018318820113545 13DesforgesM.Le CoupanecA.BrisonE.Meessen-PinardM.TalbotP.J.Neuroinvasive and neurotropic human"/>
  <result pre="infections in childrenEmerg Infect Dis162201018318820113545 13DesforgesM.Le CoupanecA.BrisonE.Meessen-PinardM.TalbotP.J.Neuroinvasive and neurotropic human" exact="respiratory" post="coronaviruses: potential neurovirulent agents in humansAdv Exp Med Biol8072014759624619619"/>
  <result pre="agents in humansAdv Exp Med Biol8072014759624619619 14BleauC.FilliolA.SamsonM.LamontagneL.Brain invasion by mouse" exact="hepatitis" post="virus depends on impairment of tight junctions and beta"/>
  <result pre="on impairment of tight junctions and beta interferon production in" exact="brain" post="microvascular endothelial cellsJ Virol891920159896990826202229 15Mao L, Jin H, Wang"/>
  <result pre="cellsJ Virol891920159896990826202229 15Mao L, Jin H, Wang M, et al." exact="Neurologic" post="manifestations of hospitalized patients with coronavirus disease 2019 in"/>
  <result pre="M, et al. Neurologic manifestations of hospitalized patients with coronavirus" exact="disease" post="2019 in Wuhan, China. JAMA Neurol. Published online April"/>
  <result pre="RNA in the cerebrospinal fluid of a patient with severe" exact="acute" post="respiratory syndromeClin Chem491220032108210914633896 17de WitE.van DoremalenN.FalzaranoD.MunsterV.J.SARS and MERS: recent"/>
  <result pre="in the cerebrospinal fluid of a patient with severe acute" exact="respiratory" post="syndromeClin Chem491220032108210914633896 17de WitE.van DoremalenN.FalzaranoD.MunsterV.J.SARS and MERS: recent insights"/>
  <result pre="and MERS: recent insights into emerging coronavirusesNat Rev Microbiol148201652353427344959 18BergmannC.C.LaneT.E.StohlmanS.A.Coronavirus" exact="infection" post="of the central nervous system: host-virus stand-offNat Rev Microbiol42200612113216415928"/>
  <result pre="of the central nervous system: host-virus stand-offNat Rev Microbiol42200612113216415928 19LiY.LiH.FanR.WenB.ZhangJ.CaoX.Coronavirus" exact="infections" post="in the central nervous system and respiratory tract show"/>
  <result pre="nervous system: host-virus stand-offNat Rev Microbiol42200612113216415928 19LiY.LiH.FanR.WenB.ZhangJ.CaoX.Coronavirus infections in the" exact="central nervous system" post="and respiratory tract show distinct features in hospitalized childrenIntervirology59201616316928103598"/>
  <result pre="Rev Microbiol42200612113216415928 19LiY.LiH.FanR.WenB.ZhangJ.CaoX.Coronavirus infections in the central nervous system and" exact="respiratory" post="tract show distinct features in hospitalized childrenIntervirology59201616316928103598 20GuJ.GongE.ZhangB.ZhengJ.GaoZ.ZhongY.Multiple organ"/>
  <result pre="respiratory tract show distinct features in hospitalized childrenIntervirology59201616316928103598 20GuJ.GongE.ZhangB.ZhengJ.GaoZ.ZhongY.Multiple organ" exact="infection" post="and the pathogenesis of SARSJ ExpMed2022005415424 21KimJ.-E.HeoJ.-H.KimH.Neurological complications during"/>
  <result pre="of SARSJ ExpMed2022005415424 21KimJ.-E.HeoJ.-H.KimH.Neurological complications during treatment of Middle East" exact="respiratory" post="syndromeJ Clin Neurol133201722728748673 22ArabiY.M.HarthiA.HusseinJ.Severe neurologic syndrome associated with Middle"/>
  <result pre="treatment of Middle East respiratory syndromeJ Clin Neurol133201722728748673 22ArabiY.M.HarthiA.HusseinJ.Severe neurologic" exact="syndrome" post="associated with Middle East respiratory syndrome corona virus (MERS-CoV)Infection434201549550125600929"/>
  <result pre="syndromeJ Clin Neurol133201722728748673 22ArabiY.M.HarthiA.HusseinJ.Severe neurologic syndrome associated with Middle East" exact="respiratory" post="syndrome corona virus (MERS-CoV)Infection434201549550125600929 23ChafekarAasiyahFieldingBurtramMERS-CoV: understanding the latest human"/>
  <result pre="Clin Neurol133201722728748673 22ArabiY.M.HarthiA.HusseinJ.Severe neurologic syndrome associated with Middle East respiratory" exact="syndrome" post="corona virus (MERS-CoV)Infection434201549550125600929 23ChafekarAasiyahFieldingBurtramMERS-CoV: understanding the latest human coronavirus"/>
  <result pre="human coronavirus threatViruses102201893 24KimJ.E.HeoJ.H.KimH.O.SongS.H.ParkS.S.ParkT.H.Neurological complications during treatment of middle east" exact="respiratory" post="syndromeJ Clin Neurol13201722723328748673 25ChenN.ZhouM.DongX.Epidemiological and clinical characteristics of 99"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet39510223202050751332007143 26CarterJohn B.SaundersVenetia A.Virology:"/>
  <result pre="JD, Rhinehart E, Jackson M, Chiarello L, and the Healthcare" exact="Infection" post="Control Practices Advisory Committee, 2007 Guideline for isolation precautions:"/>
  <result pre="Advisory Committee, 2007 Guideline for isolation precautions: preventing transmission of" exact="infectious" post="agents in healthcare settings. 28MackayI.ArdenK.An opportunistic pathogen afforded ample"/>
  <result pre="healthcare settings. 28MackayI.ArdenK.An opportunistic pathogen afforded ample opportunities: Middle East" exact="respiratory" post="syndrome coronavirusViruses9122017369 29HuiD.S.AzharE.I.KimY.-J.MemishZ.A.OhM.-d.ZumlaA.Middle East respiratory syndrome coronavirus: risk factors"/>
  <result pre="settings. 28MackayI.ArdenK.An opportunistic pathogen afforded ample opportunities: Middle East respiratory" exact="syndrome" post="coronavirusViruses9122017369 29HuiD.S.AzharE.I.KimY.-J.MemishZ.A.OhM.-d.ZumlaA.Middle East respiratory syndrome coronavirus: risk factors and"/>
  <result pre="afforded ample opportunities: Middle East respiratory syndrome coronavirusViruses9122017369 29HuiD.S.AzharE.I.KimY.-J.MemishZ.A.OhM.-d.ZumlaA.Middle East" exact="respiratory" post="syndrome coronavirus: risk factors and determinants of primary, household,"/>
  <result pre="ample opportunities: Middle East respiratory syndrome coronavirusViruses9122017369 29HuiD.S.AzharE.I.KimY.-J.MemishZ.A.OhM.-d.ZumlaA.Middle East respiratory" exact="syndrome" post="coronavirus: risk factors and determinants of primary, household, and"/>
  <result pre="systematic reviewBMC Public Health181201857429716568 31SengaM.ArabiY.M.FowlerR.A.Clinical spectrum of the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV)J Infect Public Health102201719119427140697 32Weekly epidemiological record"/>
  <result pre="reviewBMC Public Health181201857429716568 31SengaM.ArabiY.M.FowlerR.A.Clinical spectrum of the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV)J Infect Public Health102201719119427140697 32Weekly epidemiological record RelevÃ©"/>
  <result pre="No 48, 2019, 94, 561â€&quot;580 http://www.who.int/wer.(accessed Jan 25, 2020). 33Coronavirus" exact="disease" post="(COVID-19) Situation Report â€&quot; 118 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200517-covid-19-sitrep-118.pdf?sfvrsn=21c0dafe_6. (accessed May 18,"/>
  <result pre="Licence: CC BY-NC-SA 3.0 IGO (accessed Jan 25, 2020). 37HuiD.S.MemishZ.A.ZumlaA.Severe" exact="acute" post="respiratory syndrome vs. the Middle East respiratory syndromeCurr Opin"/>
  <result pre="CC BY-NC-SA 3.0 IGO (accessed Jan 25, 2020). 37HuiD.S.MemishZ.A.ZumlaA.Severe acute" exact="respiratory" post="syndrome vs. the Middle East respiratory syndromeCurr Opin Pulmonary"/>
  <result pre="BY-NC-SA 3.0 IGO (accessed Jan 25, 2020). 37HuiD.S.MemishZ.A.ZumlaA.Severe acute respiratory" exact="syndrome" post="vs. the Middle East respiratory syndromeCurr Opin Pulmonary Med203201423324124626235"/>
  <result pre="25, 2020). 37HuiD.S.MemishZ.A.ZumlaA.Severe acute respiratory syndrome vs. the Middle East" exact="respiratory" post="syndromeCurr Opin Pulmonary Med203201423324124626235 38Ji W, Wang W, Zhao"/>
  <result pre="acute respiratory syndrome vs. the Middle East respiratory syndromeCurr Opin" exact="Pulmonary" post="Med203201423324124626235 38Ji W, Wang W, Zhao X, Zai J,"/>
  <result pre="to human. J Med Virol. January 2020:jmv.25682. 39European Centre for" exact="Disease" post="Prevention and Control. Pneumonia cases possibly associated with a"/>
  <result pre="Virol. January 2020:jmv.25682. 39European Centre for Disease Prevention and Control." exact="Pneumonia" post="cases possibly associated with a novel coronavirus in Wuhan,"/>
  <result pre="25, 2020). 40WHO guidelines for the global surveillance of severe" exact="acute" post="respiratory syndrome (SARS). Updated recommendations, October 2004 WHO/CDS/CSR/ARO/2004.1 (accessed"/>
  <result pre="2020). 40WHO guidelines for the global surveillance of severe acute" exact="respiratory" post="syndrome (SARS). Updated recommendations, October 2004 WHO/CDS/CSR/ARO/2004.1 (accessed Jan"/>
  <result pre="40WHO guidelines for the global surveillance of severe acute respiratory" exact="syndrome" post="(SARS). Updated recommendations, October 2004 WHO/CDS/CSR/ARO/2004.1 (accessed Jan 25,"/>
  <result pre="Jan 25, 2020). 41Wong SF, Chow KM, de Swiet M." exact="Severe" post="acute respiratory syndrome and pregnancy. Br J Obstetrics Gynaecol,"/>
  <result pre="25, 2020). 41Wong SF, Chow KM, de Swiet M. Severe" exact="acute" post="respiratory syndrome and pregnancy. Br J Obstetrics Gynaecol, 2003,"/>
  <result pre="2020). 41Wong SF, Chow KM, de Swiet M. Severe acute" exact="respiratory" post="syndrome and pregnancy. Br J Obstetrics Gynaecol, 2003, 110:641â€&quot;642."/>
  <result pre="41Wong SF, Chow KM, de Swiet M. Severe acute respiratory" exact="syndrome" post="and pregnancy. Br J Obstetrics Gynaecol, 2003, 110:641â€&quot;642. WHO"/>
  <result pre="demographic, and clinical characteristics of 47 cases of Middle East" exact="respiratory" post="syndrome coronavirus disease from Saudi Arabia: a descriptive studyLancet"/>
  <result pre="and clinical characteristics of 47 cases of Middle East respiratory" exact="syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect"/>
  <result pre="characteristics of 47 cases of Middle East respiratory syndrome coronavirus" exact="disease" post="from Saudi Arabia: a descriptive studyLancet Infect Dis13201375276123891402 43The"/>
  <result pre="Group. State of knowledge and data gaps of Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) in humans. PLoS Curr 2013; 5."/>
  <result pre="State of knowledge and data gaps of Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) in humans. PLoS Curr 2013; 5. 44WHO"/>
  <result pre="of influenza A virus on the severity of Middle East" exact="Respiratory" post="Syndrome CoronavirusJ Infect745201752152328189714 46HuangP.WangH.CaoZ.A rapid and specific assay for"/>
  <result pre="influenza A virus on the severity of Middle East Respiratory" exact="Syndrome" post="CoronavirusJ Infect745201752152328189714 46HuangP.WangH.CaoZ.A rapid and specific assay for the"/>
  <result pre="Jan 25, 2020). 49Global surveillance for COVID-19 caused by human" exact="infection" post="with COVID-19 virus Interim guidance 20 March 2020 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical"/>
  <result pre="Clin Neurol.10th ed. Stamford, Conn: Appleton &amp;amp; Lange, 2018. 51LauK.K.YuW.C.ChuC.M.LauS.T.ShengB.YuenK.Y.Possible" exact="central nervous system" post="infection by SARS coronavirusEmerg Infect Dis102200434234415030709 52SohalS.MansurM.COVID-19 presenting with"/>
  <result pre="Stamford, Conn: Appleton &amp;amp; Lange, 2018. 51LauK.K.YuW.C.ChuC.M.LauS.T.ShengB.YuenK.Y.Possible central nervous system" exact="infection" post="by SARS coronavirusEmerg Infect Dis102200434234415030709 52SohalS.MansurM.COVID-19 presenting with seizuresIDCases202020e00782"/>
  <result pre="of meningitis/encephalitis associated with SARS-Coronavirus-2Int J Infect Dis942020555832251791 54DuongL.XuP.LiuA.Meningoencephalitis without" exact="respiratory" post="failure in a young female patient with COVID-19 infection"/>
  <result pre="J Infect Dis942020555832251791 54DuongL.XuP.LiuA.Meningoencephalitis without respiratory failure in a young" exact="female" post="patient with COVID-19 infection in Downtown Los Angeles, early"/>
  <result pre="without respiratory failure in a young female patient with COVID-19" exact="infection" post="in Downtown Los Angeles, early April 2020 [published online"/>
  <result pre="of print, 2020 Apr 10]Brain Behav Immun2020S0889-1591(20)30465-7 56UmapathiT.KorA.C.VenketasubramanianN.Large artery ischaemic" exact="stroke" post="in severe acute respiratory syndrome (SARS)J Neurol2511020041227123115503102 57TsaiL.K.HsiehS.T.ChangY.C.Neurological manifestations"/>
  <result pre="Apr 10]Brain Behav Immun2020S0889-1591(20)30465-7 56UmapathiT.KorA.C.VenketasubramanianN.Large artery ischaemic stroke in severe" exact="acute" post="respiratory syndrome (SARS)J Neurol2511020041227123115503102 57TsaiL.K.HsiehS.T.ChangY.C.Neurological manifestations in severe acute"/>
  <result pre="10]Brain Behav Immun2020S0889-1591(20)30465-7 56UmapathiT.KorA.C.VenketasubramanianN.Large artery ischaemic stroke in severe acute" exact="respiratory" post="syndrome (SARS)J Neurol2511020041227123115503102 57TsaiL.K.HsiehS.T.ChangY.C.Neurological manifestations in severe acute respiratory"/>
  <result pre="Behav Immun2020S0889-1591(20)30465-7 56UmapathiT.KorA.C.VenketasubramanianN.Large artery ischaemic stroke in severe acute respiratory" exact="syndrome" post="(SARS)J Neurol2511020041227123115503102 57TsaiL.K.HsiehS.T.ChangY.C.Neurological manifestations in severe acute respiratory syndromeActa"/>
  <result pre="severe acute respiratory syndrome (SARS)J Neurol2511020041227123115503102 57TsaiL.K.HsiehS.T.ChangY.C.Neurological manifestations in severe" exact="acute" post="respiratory syndromeActa Neurol Taiwan143200511311916252612 58Biller, JosÃ©. Practical neurology, 2017."/>
  <result pre="acute respiratory syndrome (SARS)J Neurol2511020041227123115503102 57TsaiL.K.HsiehS.T.ChangY.C.Neurological manifestations in severe acute" exact="respiratory" post="syndromeActa Neurol Taiwan143200511311916252612 58Biller, JosÃ©. Practical neurology, 2017. Fifth"/>
  <result pre="2017. Fifth edition. Philadelphia: Wolters Kluwer Heath. 59AvulaA.NalleballeK.NarulaN.COVID-19 presenting as" exact="stroke" post="[published online ahead of print, 2020 Apr 28]Brain Behav"/>
  <result pre="Immun2020S0889-1591(20)30685-1 60Al-HameedF.Spontaneous intracranial hemorrhage in a patient with Middle East" exact="respiratory" post="syndrome corona virusSMJ3822017196200 61Bashar Katirj. Disorders of peripheral nerves."/>
  <result pre="60Al-HameedF.Spontaneous intracranial hemorrhage in a patient with Middle East respiratory" exact="syndrome" post="corona virusSMJ3822017196200 61Bashar Katirj. Disorders of peripheral nerves. In:"/>
  <result pre="patient with Middle East respiratory syndrome corona virusSMJ3822017196200 61Bashar Katirj." exact="Disorders" post="of peripheral nerves. In: Bradley neurology in clinical practice."/>
  <result pre="Middle East respiratory syndrome corona virusSMJ3822017196200 61Bashar Katirj. Disorders of" exact="peripheral" post="nerves. In: Bradley neurology in clinical practice. 7th ed."/>
  <result pre="7th ed. Philadelphia, PA: Elsevier/Saunders, (2016).1791-1866. 62TsaiL.K.HsiehS.T.ChaoC.C.Neuromuscular disorders in severe" exact="acute" post="respiratory syndromeArch Neurol611120041669167315534177 63LeungT.W.WongK.S.HuiA.C.Myopathic changes associated with severe acute"/>
  <result pre="ed. Philadelphia, PA: Elsevier/Saunders, (2016).1791-1866. 62TsaiL.K.HsiehS.T.ChaoC.C.Neuromuscular disorders in severe acute" exact="respiratory" post="syndromeArch Neurol611120041669167315534177 63LeungT.W.WongK.S.HuiA.C.Myopathic changes associated with severe acute respiratory"/>
  <result pre="severe acute respiratory syndromeArch Neurol611120041669167315534177 63LeungT.W.WongK.S.HuiA.C.Myopathic changes associated with severe" exact="acute" post="respiratory syndrome: a postmortem case seriesArch Neurol62720051113111716009768 64LeeN.HuiD.WuA.A major"/>
  <result pre="acute respiratory syndromeArch Neurol611120041669167315534177 63LeungT.W.WongK.S.HuiA.C.Myopathic changes associated with severe acute" exact="respiratory" post="syndrome: a postmortem case seriesArch Neurol62720051113111716009768 64LeeN.HuiD.WuA.A major outbreak"/>
  <result pre="a postmortem case seriesArch Neurol62720051113111716009768 64LeeN.HuiD.WuA.A major outbreak of severe" exact="acute" post="respiratory syndrome in Hong KongN Engl J Med3482020031986199412682352 65StainsbyB.HowittS.PorrJ.Neuromusculoskeletal"/>
  <result pre="postmortem case seriesArch Neurol62720051113111716009768 64LeeN.HuiD.WuA.A major outbreak of severe acute" exact="respiratory" post="syndrome in Hong KongN Engl J Med3482020031986199412682352 65StainsbyB.HowittS.PorrJ.Neuromusculoskeletal disorders"/>
  <result pre="case seriesArch Neurol62720051113111716009768 64LeeN.HuiD.WuA.A major outbreak of severe acute respiratory" exact="syndrome" post="in Hong KongN Engl J Med3482020031986199412682352 65StainsbyB.HowittS.PorrJ.Neuromusculoskeletal disorders following"/>
  <result pre="a case seriesJ Can Chiropr Assoc5512011323921403780 66ShepherdS.BatraA.LernerD.P.Review of critical illness" exact="myopathy" post="and neuropathyNeurohospitalist712017414828042370 67HwangC.S.Olfactory neuropathy in severe acute respiratory syndrome:"/>
  <result pre="Chiropr Assoc5512011323921403780 66ShepherdS.BatraA.LernerD.P.Review of critical illness myopathy and neuropathyNeurohospitalist712017414828042370 67HwangC.S.Olfactory" exact="neuropathy" post="in severe acute respiratory syndrome: report of A caseActa"/>
  <result pre="of critical illness myopathy and neuropathyNeurohospitalist712017414828042370 67HwangC.S.Olfactory neuropathy in severe" exact="acute" post="respiratory syndrome: report of A caseActa Neurol Taiwan1512006262816599281 68KondziellaDanielWaldemarGunhildNeurology"/>
  <result pre="critical illness myopathy and neuropathyNeurohospitalist712017414828042370 67HwangC.S.Olfactory neuropathy in severe acute" exact="respiratory" post="syndrome: report of A caseActa Neurol Taiwan1512006262816599281 68KondziellaDanielWaldemarGunhildNeurology at"/>
  <result pre="as a clinical presentation of mild-to-moderate forms of the coronavirus" exact="disease" post="(COVID-19): a multicenter European study [published online ahead of"/>
  <result pre="online ahead of print, 2020 Apr 6]Eur Arch Otorhinolaryngol202011131664514 70AlbertiP.BerettaS.PiattiM.Guillain-BarrÃ©" exact="syndrome" post="related to COVID-19 infectionNeurol Neuroimmunol Neuroinflamm742020e741 71El Otmani H,"/>
  <result pre="(Paris). 2020;S0035-3787(20)30543-9. 72GutiÃ©rrez-Ortiz C, MÃ©ndez A, Rodrigo-Rey S, et al." exact="Miller Fisher" post="Syndrome and polyneuritis cranialis in COVID-19. Neurology. Published online"/>
  <result pre="2020;S0035-3787(20)30543-9. 72GutiÃ©rrez-Ortiz C, MÃ©ndez A, Rodrigo-Rey S, et al. Miller" exact="Fisher" post="Syndrome and polyneuritis cranialis in COVID-19. Neurology. Published online"/>
  <result pre="72GutiÃ©rrez-Ortiz C, MÃ©ndez A, Rodrigo-Rey S, et al. Miller Fisher" exact="Syndrome" post="and polyneuritis cranialis in COVID-19. Neurology. Published online April"/>
  <result pre="online April 17, 2020:10.1212/WNL.0000000000009619. 73WakerleyB.R.YukiN.Mimics and chameleons in Guillain-BarrÃ© and" exact="Miller Fisher" post="syndromesPract Neurol1522015909925239628 74HanC.WangY.JiaJ.Bickerstaff's brainstem encephalitis, Miller Fisher syndrome and"/>
  <result pre="April 17, 2020:10.1212/WNL.0000000000009619. 73WakerleyB.R.YukiN.Mimics and chameleons in Guillain-BarrÃ© and Miller" exact="Fisher" post="syndromesPract Neurol1522015909925239628 74HanC.WangY.JiaJ.Bickerstaff's brainstem encephalitis, Miller Fisher syndrome and"/>
  <result pre="in Guillain-BarrÃ© and Miller Fisher syndromesPract Neurol1522015909925239628 74HanC.WangY.JiaJ.Bickerstaff's brainstem encephalitis," exact="Miller Fisher syndrome" post="and Guillain-BarrÃ© syndrome overlap in an asthma patient with"/>
  <result pre="Guillain-BarrÃ© and Miller Fisher syndromesPract Neurol1522015909925239628 74HanC.WangY.JiaJ.Bickerstaff's brainstem encephalitis, Miller" exact="Fisher syndrome" post="and Guillain-BarrÃ© syndrome overlap in an asthma patient with"/>
  <result pre="and Miller Fisher syndromesPract Neurol1522015909925239628 74HanC.WangY.JiaJ.Bickerstaff's brainstem encephalitis, Miller Fisher" exact="syndrome" post="and Guillain-BarrÃ© syndrome overlap in an asthma patient with"/>
  <result pre="syndromesPract Neurol1522015909925239628 74HanC.WangY.JiaJ.Bickerstaff's brainstem encephalitis, Miller Fisher syndrome and Guillain-BarrÃ©" exact="syndrome" post="overlap in an asthma patient with negative anti-ganglioside antibodiesBMC"/>
  <result pre="encephalitis, Miller Fisher syndrome and Guillain-BarrÃ© syndrome overlap in an" exact="asthma" post="patient with negative anti-ganglioside antibodiesBMC Res Notes52012295Published 2012 Jun"/>
  <result pre="a World Health Organization consultationNat Med227201670170527387881 77ArabiY.M.AsiriA.Y.AssiriA.M.Treatment of Middle East" exact="respiratory" post="syndrome with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE"/>
  <result pre="World Health Organization consultationNat Med227201670170527387881 77ArabiY.M.AsiriA.Y.AssiriA.M.Treatment of Middle East respiratory" exact="syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
  <result pre="controlled trialTrials212020831900204 78ChongY.P.SongJ.Y.SeoY.B.ChoiJ.P.ShinH.S.Rapid Response TeamAntiviral treatment guidelines for Middle East" exact="respiratory" post="syndromeInfect Chemother47201521222226483999 79SunL.Y.ChuX.L.Acute myopathy following intra-muscular injection of compound"/>
  <result pre="TeamAntiviral treatment guidelines for Middle East respiratory syndromeInfect Chemother47201521222226483999 79SunL.Y.ChuX.L.Acute" exact="myopathy" post="following intra-muscular injection of compound betamethasone: a case reportMedicine"/>
 </snippets>
</snippetsTree>
